# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA260120 | 2 | EC50 | = | 1.06 | uM | ALA2156330 | 5.97 | nM | Mus musculus | ||
2. | ALA409225 | 1, SB-0304 | EC50 | = | 6.7 | nM | ALA2156330 | 8.17 | nM | Mus musculus | ||
3. | ALA2151735 | 4, BVD03 | EC50 | = | 1.3 | nM | ALA2156330 | 8.89 | nM | Mus musculus | ||
4. | ALA409225 | 1, SB-0304 | EC50 | = | 5.67 | 10'-7M | ALA2156331 | 6.25 | nM | Mus musculus | ||
5. | ALA2151735 | 4, BVD03 | EC50 | = | 1.61 | 10'-15M | ALA2156331 | nM | Mus musculus | |||
6. | ALA2151734 | 3, BVD02 | EC50 | = | 1.29 | 10'-13M | ALA2156331 | nM | Mus musculus | |||
7. | ALA260120 | 2 | EC50 | = | 5 | 10'-12M | ALA2156331 | nM | Mus musculus | |||
8. | ALA2151734 | 3, BVD02 | EC50 | = | 2.87 | 10'-10M | ALA2156330 | 9.54 | nM | Mus musculus | ||
9. | ALA2151735 | 4, BVD03 | Activity | = | 21 | % | ALA2156767 | % | Mus musculus | |||
10. | ALA2151735 | 4, BVD03 | Activity | = | 20 | % | ALA2156766 | % | Mus musculus | |||
11. | ALA409225 | 1, SB-0304 | Activity | = | 14 | % | ALA2156767 | % | Mus musculus | |||
12. | ALA409225 | 1, SB-0304 | Activity | = | 12 | % | ALA2156766 | % | Mus musculus | |||
13. | ALA2151734 | 3, BVD02 | Activity | = | 11 | % | ALA2156766 | % | Mus musculus | |||
14. | ALA260120 | 2 | Activity | = | 3 | % | ALA2156767 | % | Mus musculus | |||
15. | ALA260120 | 2 | Activity | = | 2 | % | ALA2156766 | % | Mus musculus | |||
16. | ALA2151734 | 3, BVD02 | Activity | = | 1 | % | ALA2156767 | % | Mus musculus | |||
17. | Naltrexone | naltrexone | pKi | = | 9.06 | ALA2155055 | 9.06 | nM | Mus musculus | |||
18. | ALA2151247 | 10 | pKi | = | 8.38 | ALA2155055 | 8.38 | nM | Mus musculus | |||
19. | ALA2151246 | SNC-19, 9 | pKi | = | 5.92 | ALA2155055 | 5.92 | nM | Mus musculus | |||
20. | ALA2151245 | L4, 2 | pKi | > | 9 | ALA2155055 | nM | Mus musculus |